Skip to content

An exploratory study to evaluate the efficacy of the single ingestion of milk protein hydrolysate on cerebral activity.

An exploratory study to evaluate the efficacy of the single ingestion of milk protein hydrolysate on cerebral activity. - Effect of milk protein hydrolysate on cerebral activity.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025347
Enrollment
36
Registered
2017-01-10
Start date
2017-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Milk protein hydrolysate 40mg/kg, single dose Milk protein 40mg/kg, single dose Dietary fiber (Placebo) 40mg/kg, single dose

Sponsors

Morinaga Milk Industry Co., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) More than 20 years and less than 65 years old 2) Subjects who have no problems in daily life.

Exclusion criteria

Exclusion criteria: 1) Subjects with dementia for cerebrovascular disease or Alzheimer's disease. 2) Subjects with severe diseases or medical histories 3) Subjects with milk allergy 4) Subjects continuously using supplements that may influence cerebral function; e.g. DHA, EPA, catechin. 5) Subjects who are judged inappropriate for the study by the physician.

Design outcomes

Primary

MeasureTime frame
Reaction time and correct answer ratio against cognitive tasks The cerebral blood flow

Countries

Japan

Contacts

Public ContactHirohiko Nakamura, Noriko Saito

Morinaga Milk Industry Co., LTD. Wellness & Nutrition Science Institute, R&D Division

hi_nakam@morinagamilk.co.jp046-252-3050

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026